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Imaging Cold-Activated Brown Adipose Tissue Using
Dynamic T2*-Weighted Magnetic Resonance Imaging and
2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography
Bart D. van Rooijen, PhD,* Anouk A.J.J. van der Lans, MS,Þ Boudewijn Brans, MD, PhD,þ
Joachim E. Wildberger, MD, PhD,* Felix M. Mottaghy, MD, PhD,þ§ Patrick Schrauwen, PhD,Þ
Walter H. Backes, PhD,* and Wouter D. van Marken Lichtenbelt, PhDÞ
Objectives: The objective of this study was to explore the use of magnetic reso-
nance imaging (MRI) to identify and quantify active brown adipose tissue (BAT) in
adult humans. 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) positron emission tomog-
raphy (PET) combined with computed tomography was used as a referencemethod
to identify active BAT depots and to guide the MRI data analysis.
Materials and Methods: The ethics committee of the institute approved the
protocol, and all participants provided written informed consent before partici-
pation. Both PET combined with computed tomography and MRI of BAT
were performed in 11 healthy volunteers. Brown adipose tissue was activated by
cooling the participants using a dedicated water-perfused suit. For the MRI ex-
amination of BAT, water-fat imaging and dynamic T2* imaging were performed
at an effective temporal resolution of 2 minutes per volume. Water-fat images
were derived from a multiecho MRI sequence using the Dixon technique.
Results: 2-Deoxy-2-[18F]fluoro-D-glucoseYPET identified active BAT in 8 of
the 11 participants. Water-fat MRI showed that BAT depots had a fat fraction
of 65.2% (7.0%) compared with 81.5% (5.4%) for the subcutaneous white
adipose tissue (paired difference of 16.3% [4.9%]; P G 0.05). Dynamic T2*
imaging during cold stimulation revealed signal fluctuations that were sensi-
tive to BAT activation. The presence of these components correlated with BAT
activation quantified from FDG-PET (r = 0.63; P G 0.05).
Conclusions: Although FDG-PET has superior contrast for identifying active
BAT, the MRI temporal resolution provides insight in activation dynamics. In
addition, the flexibility of MRI allows for simultaneous mapping of tissue fat
content and functional responses. The results indicate that MRI is a promising
addition to PET for the identification of BAT and its activity responses to
stimulation. An MRI-based methodology to quantify BAT activity is a highly
desirable step in addressing the role of BAT in obesity disorders.
Key Words: brown adipose tissue, magnetic resonance imaging, positron
emission tomography, thermogenesis
(Invest Radiol 2013;48: 708Y714)
Mammals have 2 distinct types of fat tissue: white adipose tissue(WAT) and brown adipose tissue (BAT). Brown adipose tissue
is strongly innervated by the sympathetic nervous system and is
much more densely vascularized than WAT.1 Brown adipose tissue is
the main site for nonshivering thermogenesis (NST) in rodents.2,3
Only recently, it was shown by positron emission tomography (PET)
using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) that adult humans
possess functionally active BAT depots and that the presence of ac-
tive BAT influences human metabolism.4 It has thus been postulated
that pharmaceutical targeting of BAT is a possible strategy in the
treatment of obesity.
The only noninvasive method to investigate the presence of
BAT has been the use of FDG-PET combined with computed to-
mography (CT). Although this method offers excellent sensitivity in
detecting active BAT, the use of ionizing radiation limits its appli-
cation on healthy human participants in research. In addition, be-
cause FDG uptake is an irreversible process, obtaining information
about the dynamics of BAT activation, such as on/off switching, is
difficult. To complement these shortcomings, an additional nonin-
vasive method is needed.
Brown adipose tissue imaging using magnetic resonance im-
aging (MRI) has been mainly performed on rodents. Results from
both fat imaging5Y7 and perfusion imaging8,9 suggest that MRI might
be a valuable tool for identifying BAT depots and characterizing BAT
activation. More recently, human BATwas identified using MRI in a
human infant.10 The aim of this study was to investigate whether
MRI can be used to characterize active BAT depots in adult humans
for water-fat composition and activity response to cold conditions.
On the basis of reported results, we hypothesized that, in MRI, both
water-fat imaging and perfusion imaging are sensitive to the presence
of active BAT. In this study, MRI was used to assess BAT fat content
(as measured by a multiecho MRI acquisition11) and BAT activation
using dynamic T2* imaging during cold exposure. In the same par-
ticipants, FDG-PET/CT during cold stimulation was performed as
the reference method for BAT activity.
MATERIALS AND METHODS
The ethics committee of the institute approved the protocol, and
all participants provided written informed consent before participation.
Study Population
Healthy human participants with an age between 18 to 30 years and
a body mass index between 18 to 30 kg/m2 were eligible for the study.
Exclusion criteria were known diabetes mellitus, the use of A-blockers,
and contraindications toMRI or ionizing radiation. Eleven young adults
(7 women and 4 men) participated in the study. See Table 1 for the
participants’ characteristics.
Study Design
All participants underwent a cooling trial experiment, a full
MRI protocol, and an FDG-PET/CT.Within 5 days of the trial, MRI and,
within 9 days, FDG-PET/CTwere performed. For the trial experiment,
MRI and PET/CT were performed after a fasting period of at least
5 hours.
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Individualized Cooling Protocol
Cooling was performed by wrapping the participant in a water-
perfused suit (Thermowrap, Universal MTRE System) connected to
2 temperature-controlled water baths (Blanketrol III, Cincinatti Sub-
Zero) comparable with the study of Ouellet et al.12
The cooling protocol was adjusted to the individual participant’s
response in the trial experiment. The participants were sequentially ex-
posed to 30 minutes of thermoneutral conditions, cooling until shiver-
ing, warm conditions for 5 minutes, and mild cold conditions (20.4-C
[1.7-C]) for 60 minutes. When the participant reported shivering during
the mild cold condition, suit temperature was increased in steps of 1-C
until no obvious muscle cramps or shivering was reported. When the
participant did not report feeling cold, suit temperature was lowered in
steps of 1-C.
The optimal water temperature for NST resulted in suit tem-
peratures in a range of 22.4-C to 26.3-C (24.1-C [1.4-C]). This in-
dividual mild cold condition was used during the PET/CT and the
dynamic T2* imaging. In few cases, the individuals reported shiv-
ering under mild cold conditions while scanning; in response, suit
temperature was raised by 1-C.
2-Deoxy-2-[18F]fluoro-D-glucoseYPET/CT Acquisition
Before the PET/CT scan, the participants were kept in thermo-
neutral conditions for 45minutes, followed by cooling until shivering and
5 minutes of warming. Subsequently, the participants were exposed to
mild cold for 90 minutes, with injection of 74 MBq of FDG intrave-
nously after 30 minutes. Hereafter, the imaging started with a CT,
followed by a PET scan (Gemini TF PET-CT; Philips, Best, The
Netherlands). The resulting total effective radiation dose for the
full examination was approximately 2.8 mSv. The PET scan covered
the neck to the kidneys, requiring 6 to 7 bed positions (6 minutes per
bed position). The CT scan was used for attenuation correction of the
PET scan and localization of the FDG uptake sites. A tube voltage of
120 kV, 30mA s per slice, and 64 0.625mm of collimation was used.
Both image sets were reconstructed with a slice thickness of 4 mm (130
to 170 slices). The in-plane resolution was 4 mm for the PETand 1 mm
for CT. The images were analyzed using PMOD (PMODTechnologies,
Zürich, Switzerland).With this software, BATactivity was quantified by
contouring the BATareas with a set threshold. These regions of interest
(ROIs) were verified by an experienced nuclear medicine physician.
Magnetic Resonance Imaging Acquisition
Magnetic resonance imaging acquisitions were conducted
on a Philips Achieva 3.0T scanner (Philips, Best, The Netherlands).
An 8-element neurovascular coil was used. The scans were positioned
to include the supraclavicular and cervical adipose depots (14-cm field
of view along the caudal-cranial axis). No respiratory compensation
was used. The participants were wrapped in the water-perfused suit.
All participants underwent the MRI protocol, which consisted of a
T1 sequence, water-fat imaging, and followed by dynamic T2* imaging
during which a cooling paradigm was performed. Before the cooling
experiment, the participants were kept in thermoneutral conditions. The
T1-weighted turbo gradient echo sequence had the following parameters:
repetition time (TR), 10 milliseconds; echo time (TE), 2.3 milliseconds;
flip angle (FA), 15 degrees; field of view (FOV), 246 mm anterior-
posterior (AP), 450 mm right-left (RL); matrix, 320  320; slice thick-
ness, 7 mm; slice gap, 1 mm; slices, 25; and acquisition time, 1 minute.
For water-fat imaging, a triple echo (for T2* correction13) gra-
dient echo acquisition was performed. From the images containing ei-
ther the sum (in-phase) or the difference (out of phase) of the water and
fat signal, separated water and fat images were derived by the scanner
software.11,14 The method was validated by measurements on a phan-
tom (see Supplemental Digital Content Fig. S1, Supplemental Digital
TABLE 1. Characteristics of the Study Participants
Characteristic Value Range
Men/women 4/7
Age, y 23.9 (2.2) 21Y28
Body mass, kg 72.4 (13.4) 50.7Y99.0
Height, m 1.8 (0.1) 1.7Y1.9
BMI, kg/m2 22.9 (3.2) 18.2Y27.7
Body fat, % 27.0 (7.9) 9.6Y35.8
Data are reported as mean (SD).
BMI indicates body mass index.
FIGURE 1. Time-series analysis. A, The repeated cooling paradigm in the dynamic T2* MRI acquisition was repeated twice
(solid line) to create four transitions in signal level. In the presence of noise and signal drift (dashed line), this improves the contrast to
noise of the signal recovery. B, A single repetition of the paradigm would result in a poor contrast to noise ratio possibly more
confounded by signal drifts. C, The ICA analysis is able to separate different independent components from a mixed signal.
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Content 1, http://links.lww.com/RLI/A86).15 The following parameters
were used: TR, 289.9 milliseconds; TE1, 2.3 milliseconds (in-phase);
TE2, 3.45 milliseconds (opposed phase); TE, 3 4.6 milliseconds (in-
phase); FA, 75 degrees; FOV, 372  465 mm (AP  RL); reconstruc-
tion matrix, 260 231; slice thickness, 6 mm; slice gap, 1 mm; slices,
20; and acquisition time, 2 minutes.
Dynamic T2*-weighted imaging was performed using gradient
echo planar imaging with the following parameters: TR, 200 milliseconds;
TE, 15 milliseconds; FA, 90 degrees; FOV, 204  450 mm (AP  RL);
reconstruction matrix, 300  298; slice thickness, 2mm; slice gap,
5 mm; and 20 slices resulting in an acquisition time per single volume
of 15 seconds. During the acquisition, no breath-hold, cardiac, or re-
spiratory triggering was used. Two minutes after the start of the dynamic
T2*-weighted acquisition, the participants were cooled until shivering
and were subsequently warmed for 5 minutes. After this, the participants
were exposed to mild cold for 10 minutes, followed by 15 minutes of
thermoneutral condition. Thewhole paradigmwas subsequently repeated
to modulate the response with a characteristic temporal signature,
which improves possible signal detection with respect to background
fluctuations (Figs. 1A, B). The duration of the protocol varied between
the participants (depending on the time in which the participants
reported shivering) and was in the range of 46 to 86 minutes.
Time-Series Analysis
Preprocessing of the dynamic T2*-weighted acquisition was
performed in MATLAB. Image noise was reduced by averaging
8 subsequent volumes. This results in an effective temporal resolu-
tion of approximately 2 minutes per volume. Motion correction was
performed by using a 2-dimensional nonrigid b-spline registration.16
Because there is limited a priori knowledge of the temporal
characteristics of BAT activation, the expected tissue time response in
the dynamic acquisition is not known. To identify possible responses
without prior knowledge of the time signature, an independent com-
ponent analysis (ICA) was performed using MELODIC.17Y19 Inde-
pendent component analysis is a mathematical data-driven method to
decompose a signal into statistically independent temporal components
(Fig. 1C). The response could, for instance, be delayed or distorted
comparedwith the stimulus. In a direct regression with the stimulus, the
contrast may then be lost. The images were masked with an ROI
representing activated BAT found on PET/CT. The ROI was delineated
FIGURE 2. 2-Deoxy-2-[18F]fluoro-D-glucoseYPET/CT of activated BAT. A, Cooling protocol for BAT imaging using PET. The
participants were cooled (dark grey) before FDG injection and exposed to NST (light grey) conditions during the imaging.
Thermoneutral conditions are depicted with a white fill. B and C, Positron emission tomography of a BAT+ participant showing
a typical FDG uptake distribution. B, The supraclavicular (sc), cervical (ce), and paraspinal (ps) depots are clearly observed in the
coronal projection. Note that the heart and the liver also show displayed FDG uptake. C, Corresponding axial slices at different levels
marked by the red lines. D, Axial slice of the low-dose CT. E, Overlay of the corresponding PET slice on the low-dose CT.
van Rooijen et al Investigative Radiology & Volume 48, Number 10, October 2013
710 www.investigativeradiology.com * 2013 Lippincott Williams & Wilkins
Copyright © 2013 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
on the T1-weighted scan on the basis of the corresponding PET/CT
slice including supraclavicular and cervical depots. The ROIs were
drawn by an experienced imaging researcher and under the supervision
of a physician who has specialty in nuclear medicine.
In addition, a model-based analysis was performed with the
FEAT linear regression analysis tool from the FSL software pack-
age.18,19 The response was modeled as a block wave derived from
the time signature of the cooling protocol and has a value of 1 during
cooling and 0 during heating and thermoneutral periods. Multiple
regression with this model was performed on each voxel. The re-
gression results are represented as z-maps containing the z-score for
the probability that the model is an accurate representation of the
corresponding voxel time trace.
Statistical Analysis
Descriptive results are reported as mean (SD). Comparison
of tissue fat content was performed using a (2-tailed) paired Student
t test. The threshold in the analysis of the activation maps was set
at a z-score of 1.65. The MRI and PET results in the supraclavi-
cular and cervical depots were compared by calculating the Pearson
correlation coefficient between the fraction of activated voxels in
dynamic T2*-weighted imaging and the activity concentration mea-
sured by PET/CT. Correlations coefficients were tested for signifi-




On the PET images, 8 of the 11 participants showed a pro-
nounced FDG uptake in BAT. For 3 participants, the FDG uptake was
negligible, and these participants did not have common characteris-
tics. A typical distribution of FDG uptake is shown in Figures 2B and
C. Uptake in the supraclavicular, cervical, and paraspinal depots was
observed. These depots can be identified as adipose tissue on the
fused PET/CT image because adipose tissue has Hounsfield units
in the range of j150 to j50 (Fig. 2D).
Water-Fat MRI
The fat depots identified on T1-weighted magnetic resonance
images corresponded visually with the regions identified on the CT
scan (Figs. 3A, B). On water-fat MRI (Fig. 3C), the adipose tissue
could clearly be observed as regions with a high pixel intensity.
Figure 3E shows the distribution of the voxel fat content of the sub-
cutaneous WAT compared with that of the internal fat depots in the
supraclavicular and cervical regions. The supraclavicular/cervical fat
depots containing BAT showed a lower fat content compared with that
of the subcutaneousWAT. The mean (SD) fat content in all participants
was 65.2% (7.0%) for the supraclavicular/cervical fat depots compared
FIGURE 3. Water-fat MRI of BAT. A, Axial slice of a T1-weighted MRI scan. B, Corresponding axial slice of the low-dose CT scan.
C, Axial slice of the fat content image of a BAT+ participant. The green contour denotes the complete supraclavicular fat depot, the
red contour indicates the region showing FDG uptake on the PET, and the blue contour is the ROI used as the subcutaneous WAT.
D,Axial PET/CT slice corresponding to the fat content image in (C). TheFDGuptake is nothomogeneous throughout theadiposedepot.
E, Normalized histogram of the fat content of voxels in the different ROIs described in (C), representing the subcutaneous WAT
(blue line), the supraclavicular/cervical fat depot (green dashed line), and the region showing the FDG uptake (red dotted line).
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with 81.5% (5.4%) for WATwith a paired difference of 16.3% (4.9%;
P G 0.05). The supraclavicular/cervical fat depots are morphologi-
cally different from the subcutaneous WAT. The subcutaneous WAT
appeared homogeneous, whereas the supraclavicular/cervical depots
were much more heterogeneous (Fig. 3C). This is also reflected in the
width of their respective fat content distributions (Fig. 3E). The PET/
CT images (Fig. 3D) showed that the active BAT is only present in
parts of the supraclavicular/cervical fat depots. Therefore, the fat dis-
tribution analysis was also performed including only regions that
showed FDG uptake on the PET/CT images. The resulting fat content
for BAT was 66.0% (9.3%), which was similar to the complete
supraclavicular/cervical depot. The mean (or median) of the fat distri-
bution of the supraclavicular/cervical fat compartments did not corre-
late with the FDG uptake.
Brown Adipose Tissue Activation by Dynamic
T2*-Weighted Imaging
Dynamic T2*-weighted imaging was used to measure physi-
ological changes in BAT during cold exposure (Figs. 4A-C). The
MRI time signal showed large fluctuations within the supraclavicular/
cervical depot (Fig. 4D). The signal responses had a large heterogeneity
in time signature (Fig. 4E). In most participants, several voxel clusters
could be found, in which fluctuations correlated with the cooling proto-
col. To independently validate the presence of such a component, the
ICAwas performed. The ICA identified a component with similar tem-
poral characteristics (Fig. 5A). No other consistent components could
be identified. Subsequently, regression with a modeled response of this
component was performed (Fig. 5B). Some activating voxels were also
found outside the ROI because the activation maps had a noisy appear-
ance. Figure 5C shows that the fraction of activating voxels in the fat
depot correlated with the activity concentration of FDG uptake of BAT
in the PET image. This correlation existed both for voxels that showed
an activation pattern similar to the model and for voxels that showed an
activation pattern with the opposite sign. T2*-weighted contrast thus
seems to be sensitive to local tissue reactions that correlate with BAT
activation and deactivation. As a control, the activation in muscle and
WATwas also assessed. The fraction of activating voxels in these tissues
did not significantly correlate significantly with the FDG activity con-
centration in the participants (Fig. 5C).
DISCUSSION
Recent work has shown that water-fat imaging is useful to
identify BAT in animal models5,6,8,9 and in human newborn.10 The
FIGURE 4. T2*-weighted images of BAT activation. A, Design of the cooling protocol for dynamic T2* imaging. The duration
and timing of thermoneutral (white), cold (dark grey), andmild cold conditions (light grey) are shown. B, T1-weighted (anatomical)
axial MRI slice. C, The T2*-weighted slice corresponding to the slice in (B). D, Normalized signal fluctuations averaged from a
3 3 voxels large ROI in muscle (dotted lines) and BAT (solid line). The location of the ROIs is shown in (B). The grey areas represent
the time points at which the participant was exposed to cold or mild cold conditions. The BAT T2* signal shows fluctuations with a
characteristic temporal signature that correlates with the cooling paradigm. E, The individual time traces in the 3  3 BAT
ROI shows the signal heterogeneity in the ROI.
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applicability and validity of these techniques have not been shown
in human adults. This study is an exploration of the use of MRI for
identifying active BAT in adult humans. 2-Deoxy-2-[18F]fluoro-D-
glucoseYPET was used as the reference standard because this tech-
nique has been shown to reliably detect active BAT depots.20
The MRI-derived fat fraction of the supraclavicular/cervical
adipose depot was approximately 66.0%, which was considerably
lower compared with the subcutaneous WAT with a fat fraction of
81.5%. Using a similar MRI method for water-fat separation in rats,
Hu et al6 found a fat fraction of approximately 50% for juveniles
increasing to 60 % at older age. Recent evidence suggests that the
fat content in BAT of newborn humans is lower than that in WAT.10
The fat fraction in the supraclavicular/cervical adipose depots mea-
sured in our study is thus in a similar range as has been reported for
BAT. However, our results may suggest that the fat fraction is a
general property of these depots and may not be representative of the
presence of active BAT. First, the fat fraction of the regions in the
supraclavicular/cervical depots showed that FDG uptake was not
significantly different from the adjacent adipose tissue. The regions
showing FDG uptake on the PET were visually indiscernible from
the adjacent adipose tissue on the MRI fat-content images. Second,
the fat fraction of the supraclavicular/cervical fat depots did not
correlate with the FDG uptake on the PET/CT. Whether this is related
to cellular or tissue organizational differences cannot be determined
at this spatial resolution. Recent studies suggest that the human su-
praclavicular and cervical adipose depot is a mix of brown and white
adipocytes, in contrast to the distinct BAT depots found in rodents.21,22
In humans, brown adipocytes were found to be organized in small
islands and the depot contained, on average, 13% brown adipocytes.22
Identification of active BAT based on tissue fat content alone might
therefore be difficult in adult humans. Performing simultaneous PET-
MRI could provide a more accurate characterization of BAT proper-
ties. A more reliable delineation of active BATwith the water-fat MRI
would provide a more accurate segmentation of the BAT depot and,
thus, a better estimate of active BAT fat content.
Brown adipose tissue activation is associated with enhanced
tissue perfusion.23 Increased blood flow would support the higher
metabolic rate.24 In addition, for effective thermogenesis, the produced
heat needs to be transported to the body core tissues. T2*-weighted
imaging has been extensively used to map brain perfusion in functional
MRI but has also been successfully applied to other tissues such as the
skeletal muscle25,26 and the spinal cord.27,28 Recent work by Khanna
and Branca9 using T2*-weighted imaging in mice has shown that im-
age contrast was sensitive to pharmacological activation of BAT. Dur-
ing cold activation, we observed T2*-weighted signal fluctuations
from BAT that coincided temporally with the cold stimulus. The pres-
ence of such a component suggests that BAT on/off switching is rapid
and occurs at the scale of minutes. Such a temporal response corre-
sponds to a sympathetic activation of BAT as found in rodents.3 The
identification of this component was confirmed by the ICA, which has
been proven a useful technique in identifying physiological responses
in brain functional MRI.29 The presence of such signal components, as
quantified by the model-based regression analysis, correlated with BAT
activity. This means that the T2*-weighted signal is sensitive to BAT
activation. However, the origin of this signal is not yet completely clear.
In the brain, the T2*-weighted signal is sensitive to perfusion through
the blood oxygenation levelYdependent (BOLD) effect, which influences
the T2* decay. The decrease in the concentration of deoxyhemoglobin in
well-perfused vessels causes a small signal increase in the order of 3%
to 5% at 3 T. The magnitude of the signal changes observed in BAT
was much larger and therefore cannot be attributed to the BOLD effect
alone. Larger fluctuations in the T2*-weighted signal may have a differ-
ent physiological origin as has been suggested previously in the spine and
the muscle.30,31 The T2*-weighted signal is sensitive to numerous other
effects, such as blood volume, motion, and T1 relaxation time effects
such as blood in/out flow. In addition, a priori, it remains unknown
whether (absolute and/or relative) BOLD responses are similar in
neuronal, muscle, and adipose tissue for reasons of likely differences
between tissue background signal, metabolism, and coupling between
blood vessels and tissue. Pinpointing the mechanisms underlying the
FIGURE 5. Analysis of BAT activation during T2* imaging
compared with PET. A, Example of a component identified by
the ICA (black circles). The component is modeled as a square
wave with a value of 1 during cold exposure and 0 during
thermoneutral conditions (red line). The blue areas indicate the
time points during which the participants were exposed to
cooling and mild cold conditions. B, Overlay of a color-coded
activation map of the supraclavicular/cervical fat depot onto
an axial slice of a T1-weightedMRI image. C, Scatterplot of BAT
activation in all participants asmeasured by PET (FDG uptake in
kilobecqerels per milliliters) and MRI (the fraction of activating
pixels in the supraclavicular/cervical ROI). The activation was
also measured in muscle, WAT, and BAT.
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sensitivity to BAT activation is challenging. First of all, the sign of
the signal change was undetermined because both were present and
correlated with BATactivity. In addition, the image quality suffered from
several artifacts. Breathing artifacts in the lung region and pulsation
artifacts from the carotid arteries were visible on the T2*-weighted im-
ages. Compared with T2*-weighted imaging of the brain, movement
artifacts are more difficult to correct because of the nonrigid nature of the
anatomy under consideration. All of these effects contribute to some
extent to the T2*-weighted signal and therefore might also explain the
low specificity of measuring BAT activation with the proposed method.
For instance, in the muscle, we found that the fraction of activating voxels
showed a similar trend as that of BAT. However, this trend was weaker
than that of BAT and not statistically significant. Whether this is a bio-
logical effect (for instance, through reduced muscle perfusion to reduce
heat loss), an effect of movement artifacts or signal from BAT spreading
through phase artifacts remains to be determined. Therefore, the use of
MRI needs to be further refined before matching the specificity of FDG-
PET/CT for the identification of active BAT. However, the presence of
signal components that correlate with FDG uptake is promising for the
identification of BAT using perfusion-based MRI methods.
In summary, we have presented a functional and structural MRI
exploration of BAT in humans combined with FDG-PET/CT. Water-fat
imaging using MRI showed that active BAT cannot be discerned on the
basis of tissue fat content. Dynamic imaging of BAT activation using
T2*-weighted MRI during cold stimulation is promising for the iden-
tification of active BAT. During cold stimulation, BAT activation
modulated the T2*-weighted signal. Although T2*-weighted image
contrast seemed sensitive to activation, MRI of BAT is challenging
because of the presence of susceptibility and physiological artifacts.
Compared with T2*-weightedMRI, activated BAT can be identified by
FDG-PETwith a stronger contrast. However, in contrast to MRI, tem-
poral and quantitative information on tissue fat content is lacking.
Additional advanced MRI techniques, such as spin-echo echo-planar
imaging and arterial spin labeling, can be used to obtain more de-
tailed information on changes in blood flow, volume, and oxygenation
of active BAT. Future work will also need to focus on the tailoring of an
MRI method that is both sensitive and specific enough to make full use
of the advantages of MRI over PET/CT and that stimulates research
on combined PET/MRI systems.32,33
REFERENCES
1. Cinti S. Between brown and white: novel aspects of adipocyte differentiation.
Ann Med. 2011;43:104Y115.
2. Wijers SL, Saris WH, van Marken Lichtenbelt WD. Recent advances in
adaptive thermogenesis: potential implications for the treatment of obesity.
Obes Rev. 2009;10:218Y226.
3. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological
significance. Physiol Rev. 2004;84:277Y359.
4. Vijgen GH, Bouvy ND, Teule GJ, et al. Brown adipose tissue in morbidly obese
subjects. PLoS One. 2011;6:e17247.
5. Branca RT, Warren WS. In vivo brown adipose tissue detection and charac-
terization using water-lipid intermolecular zero-quantum coherences. Magn
Reson Med. 2011;65:313Y319.
6. Hu HH, Smith DL Jr, Nayak KS, et al. Identification of brown adipose tissue
in mice with fat-water IDEAL-MRI. J Magn Reson Imaging. 2011;31:1195Y1202.
7. Chen YI, Cypess AM, Sass CA, et al. Anatomical and functional assessment of
brown adipose tissue by magnetic resonance imaging. Obesity (Silver Spring).
2012;20:1519Y1526.
8. Sbarbati A, Cavallini I, Marzola P, et al. Contrast-enhanced MRI of brown
adipose tissue after pharmacological stimulation. Magn Reson Med. 2006;55:
715Y718.
9. Khanna A, Branca RT. Detecting brown adipose tissue activity with BOLD
MRI in mice. Magn Reson Med. 2012;68:1285Y1290.
10. Hu HH, Tovar JP, Pavlova Z, et al. Unequivocal identification of brown adipose
tissue in a human infant. J Magn Reson Imaging. 2012;35:938Y942.
11. DixonWT. Simple proton spectroscopic imaging.Radiology. 1984;153:189Y194.
12. Ouellet V, Labbe SM, Blondin DP, et al. Brown adipose tissue oxidative me-
tabolism contributes to energy expenditure during acute cold exposure in
humans. J Clin Invest. 2012;122:545Y552.
13. Kuhn JP, Evert M, Friedrich N, et al. Noninvasive quantification of hepatic fat
content using three-echo Dixon magnetic resonance imaging with correction
for T2* relaxation effects. Invest Radiol. 2011;46:783Y789.
14. Szumowski J, Coshow WR, Li F, et al. Phase unwrapping in the three-point
Dixon method for fat suppression MR imaging. Radiology. 1994;192:555Y561.
15. Kang BK, Yu ES, Lee SS, et al. Hepatic fat quantification: a prospective
comparison of magnetic resonance spectroscopy and analysis methods for
chemical-shift gradient echo magnetic resonance imaging with histologic as-
sessment as the reference standard. Invest Radiol. 2012;47:368Y375.
16. Rueckert D, Sonoda LI, Hayes C, et al. Nonrigid registration using free-form
deformations: application to breast MR images. IEEE Trans Med Imaging.
1999;18:712Y721.
17. Beckmann CF, Smith SM. Probabilistic independent component analysis for
functional magnetic resonance imaging. IEEE Trans Med Imaging. 2004;23:
137Y152.
18. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and
structural MR image analysis and implementation as FSL. Neuroimage.
2004;23(suppl 1):S208Y219.
19. Woolrich MW, Jbabdi S, Patenaude B, et al. Bayesian analysis of neuroimaging
data in FSL. Neuroimage. 2009;45:S173YS186.
20. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in
healthy adults. N Engl J Med. 2009;360:1518Y1525.
21. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-
activated brown adipose tissue in healthy men. N Engl J Med. 2009;360:
1500Y1508.
22. Zingaretti MC, Crosta F, Vitali A, et al. The presence of UCP1 demonstrates
that metabolically active adipose tissue in the neck of adult humans truly
represents brown adipose tissue. FASEB J. 2009;23:3113Y3120.
23. Orava J, Nuutila P, Lidell ME, et al. Different metabolic responses of human
brown adipose tissue to activation by cold and insulin. Cell Metab. 2011;14:
272Y279.
24. Foster DO, Frydman ML. Tissue distribution of cold-induced thermogenesis in
conscious warm- or cold-acclimated rats reevaluated from changes in tissue
blood flow: the dominant role of brown adipose tissue in the replacement of
shivering by nonshivering thermogenesis. Can J Physiol Pharmacol. 1979;57:
257Y270.
25. Versluis B, Backes WH, van Eupen MG, et al. Magnetic resonance imaging in
peripheral arterial disease: reproducibility of the assessment of morphological
and functional vascular status. Invest Radiol. 2011;46:11Y24.
26. Ledermann HP, Schulte AC, Heidecker HG, et al. Blood oxygenation level-
dependent magnetic resonance imaging of the skeletal muscle in patients
with peripheral arterial occlusive disease. Circulation. 2006;113:2929Y2935.
27. Stroman PW, Tomanek B, Krause V, et al. Mapping of neuronal function in
the healthy and injured human spinal cord with spinal fMRI. Neuroimage.
2002;17:1854Y1860.
28. Backes WH, Mess WH, Wilmink JT. Functional MR imaging of the cervical
spinal cord by use of median nerve stimulation and fist clenching. AJNR Am J
Neuroradiol. 2001;22:1854Y1859.
29. McKeown MJ, Jung TP, Makeig S, et al. Spatially independent activity patterns
in functional MRI data during the Stroop color-naming task. Proc Natl Acad
Sci U S A. 1998;95:803Y810.
30. Stroman PW. Magnetic resonance imaging of neuronal function in the spinal
cord: spinal FMRI. Clin Med Res. 2005;3:146Y156.
31. Kos S, Klarhofer M, Aschwanden M, et al. Simultaneous dynamic blood ox-
ygen level-dependent magnetic resonance imaging of foot and calf muscles:
aging effects at ischemia and postocclusive hyperemia in healthy volunteers.
Invest Radiol. 2009;44:741Y747.
32. Bini J, Izquierdo-Garcia D, Mateo J, et al. Preclinical evaluation of MR at-
tenuation correction versus CT attenuation correction on a sequential whole-
body MR/PET scanner. Invest Radiol. 2013;48:313Y322.
33. Stolzmann P, Veit-Haibach P, Chuck N, et al. Detection rate, location, and size
of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT
and Dixon-based MR imaging. Invest Radiol. 2013;48:241Y246.
van Rooijen et al Investigative Radiology & Volume 48, Number 10, October 2013
714 www.investigativeradiology.com * 2013 Lippincott Williams & Wilkins
Copyright © 2013 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
